BRAF and melanoma: BRAF mutations (frequently V600E) are present in the Caucasian population in about 50% of malignant melanomas and lead to constitutive activation of the MAPK signalling pathway, which in turn mediates several phenomena, including cell proliferation, differentiation, and secretion of signal molecules, related to melanoma occurrence and progression.